Image pharmaphorum Editor News Drug firms fight US government's Iraq corruption probe US Department of Justice investigating J&J, Pfizer, Roche and others News Pain Therapeutics' opioid drug fails to gain FDA approval The US regulator has rejected Pain Therapeutics' abuse-deterrent opioid painkiller drug, Remoxy, for the fourth time. Market Access FDA grants leukaemia drug ‘breakthrough’ status A leukaemia drug has been granted ‘breakthrough therapy’ status by the US drug regulator. News New tuberculosis drug could help eradicate global killer A groundbreaking drug, rifampin, could help to end the global tuberculosis epidemic, according to researchers. Load more results
News Drug firms fight US government's Iraq corruption probe US Department of Justice investigating J&J, Pfizer, Roche and others
News Pain Therapeutics' opioid drug fails to gain FDA approval The US regulator has rejected Pain Therapeutics' abuse-deterrent opioid painkiller drug, Remoxy, for the fourth time.
Market Access FDA grants leukaemia drug ‘breakthrough’ status A leukaemia drug has been granted ‘breakthrough therapy’ status by the US drug regulator.
News New tuberculosis drug could help eradicate global killer A groundbreaking drug, rifampin, could help to end the global tuberculosis epidemic, according to researchers.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.